Bill Commons

WI SB 68

enacted

Relating to: the prescription drug monitoring program. (FE)

Wisconsin · 2025-2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did WI SB 68 pass?

Yes. WI SB 68 has been enacted into law. Latest recorded action (2025-03-28): Published 3-29-2025

What is WI SB 68 about?

WI SB 68 is a bill in the 2025-2026 Regular Session titled “Relating to: the prescription drug monitoring program. (FE)”.

Who sponsors WI SB 68?

Testin is the primary sponsor of WI SB 68, joined by 1 cosponsor.

Introduced
2025-02-24
Latest action
2025-03-28 — Published 3-29-2025
Bill type
bill
Last updated
—

Sponsors

  • Testinprimary
  • Dittrichcosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2025-03-28

    Published 3-29-2025

    became-law

  2. 2025-03-28

    Report approved by the Governor on 3-28-2025. 2025 Wisconsin Act 5

    executive-signature

  3. 2025-03-24

    Presented to the Governor on 3-24-2025

    executive-receipt

  4. 2025-03-21

    Report correctly enrolled

    enrolled

  5. 2025-03-20

    Received from Assembly concurred in

    receipt

  6. 2025-03-20

    Ordered immediately messaged

  7. 2025-03-20

    Read a third time and concurred in

    passage,reading-3

  8. 2025-03-20

    Rules suspended

  9. 2025-03-20

    Ordered to a third reading

    reading-3

  10. 2025-03-20

    Read a second time

    reading-2

  11. 2025-03-20

    Rules suspended to withdraw from calendar and take up

    withdrawal

  12. 2025-03-18

    Placed on calendar 3-20-2025 by Committee on Rules

  13. 2025-03-18

    Read first time and referred to committee on Rules

    reading-1,referral-committee

  14. 2025-03-18

    Received from Senate

    receipt

  15. 2025-03-18

    Ordered immediately messaged

  16. 2025-03-18

    Read a third time and passed

    passage,reading-3

  17. 2025-03-18

    Rules suspended to give bill its third reading

  18. 2025-03-18

    Ordered to a third reading

    reading-3

  19. 2025-03-18

    Read a second time

    reading-2

  20. 2025-03-14

    Placed on calendar 3-18-2025 pursuant to Senate Rule 18(1)

  21. 2025-03-13

    Representative Subeck added as a cosponsor

  22. 2025-03-12

    Representatives Stubbs and Moore Omokunde added as cosponsors

  23. 2025-03-07

    Available for scheduling

  24. 2025-03-07

    Report passage recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 5, Noes 0

    committee-passage-favorable

  25. 2025-03-07

    Executive action taken

  26. 2025-03-06

    Public hearing held

  27. 2025-03-05

    Fiscal estimate received

    receipt

  28. 2025-02-24

    Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families

    reading-1,referral-committee

  29. 2025-02-24

    Introduced by Senator Testin; cosponsored by Representative Dittrich

    introduction

Versions

Documents

Votes

  • Report passage recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 5, Noes 0

    2025-03-07 · pass · 5-0

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-11-01T00:24:08.546092Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=WI&identifier=SB 68. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.